folder Filed in Funding daily
Abogen Biosciences raised $700 million in Series C
By Tsani Gramatikova access_time 1 min read

What is Abogen Biosciences?

Abogen Biosciences is a biotechnology company.

What does Abogen Biosciences do?

The company is focused on developing nucleic acid-based (RNA and DNA) therapeutics for the treatment of cancer and infectious diseases.

Who owns Abogen Biosciences?

Abogen Biosciences was founded in 2019 and is also known as Suzhou Abogen Biosciences.

How much has Abogen Biosciencesraised?

The company announced that it raised $700 million in Series C, bringing the total funding amount to $814.3 million over three rounds.

Who has invested in Abogen Biosciences?

21 investors fund Abogen Biosciences. Firstred Capital and Kaiser Permanente Ventures are the most recent investors.

What domain name does Abogen Biosciences operate on?

Abogen Biosciences has chosen domain name.

Related reads

8 Mistakes entrepreneurs make when buying domain names

The trends and best practices around naming a brand: Interview with Mark Gunnion

Why investing in your branding is the best strategy for your business